Investing.com - Charles&Colvard (NASDAQ: CTHR) reported second quarter EPS of $-0.030, $0.02 worse than the analyst estimate of $-0.010. Revenue for the quarter came in at $10.4M versus the consensus estimate of $11M.
Charles&Colvard's stock price closed at $1.010. It is up 8.600% in the last 3 months and down -54.690% in the last 12 months.
Charles&Colvard saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Charles&Colvard's stock price’s past reactions to earnings here.
According to InvestingPro, Charles&Colvard's Financial Health score is "fair performance".
Check out Charles&Colvard's recent earnings performance, and Charles&Colvard's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar